

Aeglea BioTherapeutics Holdings, LLC develops drugs for the treatment of tumors. The company was incorporated in 2013 and is based in Texas.
| Headquarter | 815-A BRAZOS STREET, #101 Austin, TX United States of America |
|---|---|
| Website | aegleabio.com |
| Founding Date | 2013 |
| Tel | (512)942-2935 |
| Company Status | Public |
| Stock | AGLE |
Aeglea BioTherapeutics competitors include Pfizer and Alafair Biosciences. Aeglea BioTherapeutics ranks 2nd in Overall Culture Score on Comparably vs its competitors. See below how Aeglea BioTherapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
1 employee at Aeglea BioTherapeutics has reviewed Aeglea BioTherapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users in Austin about their company is that it was very prepared on their first day. Austin employees concluded that their overall onboarding experience was positive. 76% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Aeglea BioTherapeutics employees have provided insight into whether or not they clearly understand Aeglea BioTherapeutics' KPIs and OKRs.

Anthony Quinn CEO / President
Dr. Anthony G. Quinn, M.B Ch.B., Ph.D., FRCP, is a Director of Generation Bio Co. Dr. Quinn has been an Interim Chief...

Charles York II, M.B.A. Chief Financial Officer and Vice President
Mr. Charles N. York, II, M.B.A., has been the Chief Financial Officer and Vice President of Aeglea Biotherapeutics, Inc....

George Georgiou Ph.D. Co-Founder and Director
Prof. George Georgiou, Ph.D. is the Co-Founder of Aeglea Biotherapeutics, Inc. (formerly Aeglea BioTherapeutics...

Scott W. Rowlinson Ph.D. Vice President of Research
Dr. Scott W. Rowlinson, Ph.D. has been Vice President of Research of Aeglea Biotherapeutics, Inc. since February 2014....

Charles York CFO
Charles York serves as the CFO of Aeglea BioTherapeutics. Charles started at Aeglea BioTherapeutics in Jul of 2014....

Jim Joffrion Vice President Clinical Operations
Jim Joffrion serves as the Vice President Clinical Operations of Aeglea BioTherapeutics. Jim started at Aeglea...

Leslie Sloan SVP Operations
Leslie Sloan serves as the SVP Operations of Aeglea BioTherapeutics. Leslie started at Aeglea BioTherapeutics in Feb of...

Cortney Caudill Vice President of Manufacturing
Cortney Caudill serves as the Vice President of Manufacturing of Aeglea BioTherapeutics. Cortney started at Aeglea...

James Wooldridge Chief Medical Officer
James Wooldridge serves as the Chief Medical Officer of Aeglea BioTherapeutics. James started at Aeglea BioTherapeutics...
Leading members of the Aeglea BioTherapeutics Human Resources Team include Eugene Sackett and Greg King.

Eugene Sackett Vice President Human Resources
Eugene Sackett serves as the Vice President Human Resources of Aeglea BioTherapeutics. Eugene started at Aeglea...

Greg King HR Business Partner
Greg King serves as the HR Business Partner of Aeglea BioTherapeutics. Greg currently resides in the Austin, Texas Area.

No Recent Jobs found for Aeglea BioTherapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
In 2019, Aeglea BioTherapeutics applied for 2 H1B visas. Of the work permits applied for, 50% were approved.
An in-depth look at ‘Certified-withdrawn’ H1B applications at Aeglea BioTherapeutics unveil that one approved work permit application was withdrawn before the employee’s start date.
H1B Applications Outcome
This data was calculated using publicly sourced data from OFLC Performance Data

Candidates By Department
All Industries | 100% |
|---|
Candidates By Location
Albuquerque | 100% |
|---|
What is Aeglea BioTherapeutics address?
Aeglea BioTherapeutics location is at 815-A BRAZOS STREET, #101
What is Aeglea BioTherapeutics revenue?
Aeglea BioTherapeutics revenue is $5M
Who are Aeglea BioTherapeutics competitors?
Aeglea BioTherapeutics main competitors are Pfizer, Alafair Biosciences
Who is Aeglea BioTherapeutics leadership?
Charles York Ii, M.b.a., George Georgiou Ph.d. & Scott W. Rowlinson Ph.d. are part of Aeglea BioTherapeutics leadership, Anthony Quinn is the CEO